Navigation Links
The MedZilla.com Employment Report for October, 2013: Economy Continues to Grow Despite Government Shut-down
Date:10/24/2013

Seattle, WA (PRWEB) October 24, 2013

According to the global outplacement firm Challenger, Grey & Christmas, planned job cuts fell to their lowest level in three months. Job creators in the U.S. declared their intentions to shrink payrolls by 40,289 in September. However, those numbers decreased significantly- down 20 percent from August, when payroll cuts peaked at 50,462. (challengergray.com, 10/3/2013) While the latest report from the government has been put on the shelf this month due to the shutdown, private reports estimate the unemployment rate has held steady at around 7.3%. (adpemploymentreport.com, 10/2/2013)

"It is unfortunate timing as far as the actual reporting goes. However, there are many private firms which are constantly tracking changes in the labor market. This isn't the first time the country has had to make adjustments due to turmoil in the Capitol, unfortunately. At the same time, I like to think one of our greatest strengths as a nation is our ability to come together and show solidarity -- unity, if you will, especially when things seem they're at their most divisive. We will pull through this as well and get up and running again," encourages John Burkhardt Managing Director of MedZilla.com.

Reaching out to clients can be a good way to push through difficult business transitions. In Pharmaceutical Sales this is especially vital and the best reps in the industry are being incentivized to new levels, not only to be retained by their current companies, but in the hopes of being lured away by competitors. In the coming economic landscape, there is a great deal of speculation as to what types of incentives may tip the scales for the top level sales rep.

In the past, cars and lucrative salaries have caught the attention of the younger reps in the field, while others are more interested in what kinds of benefits packages are being offered. GlaxoSmithKline caused a stir when it switched it's incentive model to a customer service based approach unlike the sales target based profit share which was standard for the industry. Gerry Melillo, the president of sales services at the contract sales firm PDI, states: "most companies have not followed GSK" referring to the company's method for evaluating sales representatives and the awarding of bonuses. (pharmexec.com, 10/1/2013)

According to a recent survey of doctors by CMI/Compass, in general, they agreed they were less available to sales reps, less than half said they'd actually seen a sales rep in person without restrictions. Many physicians in the poll admitted to yielding the ultimate decision of which drug to prescribe up to the formulary committees supervising the networks of clinics and hospitals, where most physicians now practice. Compliance measures may only increase that practice.

"Right now it is especially important to pay attention to feedback being offered from the physicians and from the reps themselves. The landscape of healthcare has turned a corner. The healthcare bill has effected how doctors are making decisions regarding what medications to prescribe. Doctors are moving away from private companies leaving samples in offices and towards what the government recommendations are. Representatives may find their positions evolving from customer service to lobbying positions as a matter of course," says Del Johnston, Manager of Client Relations at MedZilla.com.

**********************************************************************************************************

About MedZilla.com:

Established in mid-1994, MedZilla is the original and leading web site to serve career and hiring needs for professionals and employers in biotechnology, pharmaceuticals, medicine, science and healthcare. The MedZilla jobs database contains about 7,500 open positions. The resume database currently contains over 295,000 resumes with 26,500 less than three months old. These resources have been characterized as the largest, most comprehensive databases of their kind on the web in the industries served.

MedZilla(R) is a Registered Trademark owned by MedZilla Inc. Copyright (C)MedZilla, Inc. Permission is granted to reproduce and distribute this text in its entirety, and if electronically, with a link to the URL http://www.medzilla.com. For permission to quote from or reproduce any portion of this message, please contact MedZilla, Inc. at press(at)medzilla(dot)com

Press Inquiries
Contact: MedZilla, Inc.
Phone: (360) 657-5681
press(at)medzilla(dot)com

###

Read the full story at http://www.prweb.com/releases/2013/10/prweb11263635.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. The MedZilla.com Employment Report for September, 2013: New Bio-Tech Advancements Mean More Jobs in Related Fields
2. The MedZilla.com Employment Report for July, 2013: Nation's Economy Makes Substantial, Demonstrable Improvements
3. ?The MedZilla.com Employment Report for April, 2013: Unemployment Rate Drops as Obama Announces Major Bio-Tech Research Initiative
4. The MedZilla.com Employment Report for February, 2013: Health Care Sector Stimulates Job Growth Throughout the Recession
5. MedZilla.com Launches New Site Design for 2013, Slick New Interface Impresses
6. ?The MedZilla.com Employment Report for January, 2013: Wrapping Up the Year in Employment Statistics: Recovery Efforts and the Coming Effects
7. Medzilla.com Special Report: Unemployed Can Breathe a Little Freer After Supreme Court's Affordable Care Act Ruling
8. Tech Employment Continues to Grow in July Despite Slowdown in Life Sciences
9. MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace
10. BioSpace Releases 2013 Life Sciences / Biotech Employment Outlook
11. The Medzilla Employment Report for December, 2012: Unemployment Drops to Lowest Rate in 4 Years; Experts Predict Unprecedented Growth in Healthcare IT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... March 23, 2017 Kineta, Inc., a ... novel therapies in immuno-oncology, today announced the discovery ... molecule compounds that activate interferon response factor 3 ... demonstrate immune-mediated tumor regression in a murine colon ... who demonstrated complete tumor regression to initial drug ...
(Date:3/23/2017)... New York , March 23, 2017 ... blood plasma products and derivatives market is fragmented due to the presence ... players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete ... leader, these three companies, collectively, held more than 76% of this ... ...
(Date:3/23/2017)... YORK , March 23, 2017 ... look at four equities in the Biotech industry: Sangamo ... Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics ... 21 st , 2017, Credit Suisse upgraded its rating on ... by downloading their free report at: ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
Breaking Biology Technology:
(Date:3/2/2017)... 2, 2017 Summary This report provides ... its partnering interests and activities since 2010. ... Read the full report: ... since 2010 report provides an in-depth insight into the partnering ... On demand company reports are prepared upon purchase ...
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
(Date:2/28/2017)... , February 28, 2017 News solutions for ... ... from 14 to 16 March, Materna will present ... show how seamless travel is a real benefit for passengers. ... biometrics to their passenger touch point solutions to take passengers through ...
Breaking Biology News(10 mins):